Cargando…
Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
BACKGROUND: Lung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival rate of lower than 20% among patients with advanced lung cancer. This study aims to construct a risk model to guide immunotherapy in LUAD patients effectively. MATERIALS AND METHODS: LUAD Bulk RNA-...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424935/ https://www.ncbi.nlm.nih.gov/pubmed/37583701 http://dx.doi.org/10.3389/fimmu.2023.1177847 |